Ijeoma Uchegbu is Chair in Pharmaceutical Nanoscience at University College London. She has studied the mechanisms of drug transport across biological barriers and created transformational drug transport nanoparticles. She was the first to show that peptides could be delivered across the blood brain barrier to elicit a pharmacological response when presented as nanofibers. These findings led to the enkephalin pain medicine, designed to address the opioid crisis. Three other medicine candidates based on this nanotechnology have been out-licensed to pharmaceutical companies in the US. As UCL’s Pro Vice Provost for Africa and the Middle East, she leads on the international research and teaching engagement strategy in this region.
Fellow
Back to directory listingProfessor Ijeoma Uchegbu FMedSci
Job Title
Chair in Pharmaceutical Nanoscience
Department
UCL School of Pharmacy
Institution
University College London (UCL)
Year elected
2021
Interests
SpecialitiesPreclinical study of drug transport to control drug transport to areas of pathology using nanotechnology. Developing new therapeutics with enhanced efficacy and limited side effects.
Section committee elected byNeuroscience (including neurology and neurosurgery), physiology, pharmacological sciences
Online Information